Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > ERA-NET EuroNanoMed Allocates €8 Million to European Transnational Research Projects in Nanomedicine

Abstract:
Eight projects from 10 countries were chosen to be funded as part of the 2nd call

The 3rd call will be launched in January 2011

ERA-NET EuroNanoMed Allocates €8 Million to European Transnational Research Projects in Nanomedicine

Saclay, France | Posted on November 10th, 2010

EuroNanoMed, a European funding initiative under the ERA-Net scheme of the European Commission aimed at advancing transnational research in Nanomedicine, announced today the projects that will be funded following its 2nd joint transnational call for collaborative research projects. Eight projects, involving 46 partners from 10 countries will be funded with €8 Million provided by EuroNanoMed partners. The research projects were chosen from 33 applications involving 178 applicant groups from 19 EU member and associated states/regions.

The 2nd joint transnational call for proposals was launched by ERA-Net EuroNanoMed in March 2010 to promote collaborative and interdisciplinary research in Nanomedicine. The call focused on the three main subfields of Nanomedicine: diagnostics, targeted delivery systems and regenerative medicine. The applications were reviewed by external referees, taking into account the scientific, technical, clinical and commercial merit of the projects, followed by evaluation of an international peer review panel. The 8 funded projects encompass all three subfields of Nanomedicine covering diverse medical issues such as cancer, inflammatory diseases, bone regeneration, muscular dystrophy, immunology and vaccines.

Dr. Virginie Sivan, Coordinator and Chair of the Executive Board of ERA-Net EuroNanoMed said, "Nanomedicine is the medicine of the future. It has the potential of revolutionizing every aspect of health care, including diagnostics, imaging, drug delivery and sophisticated therapies. As evident by the excellent projects selected by ERA-Net EuroNanoMed, Europe is a central player in biological nano-research. I am convinced that the quality and diversity of the selected projects will help advance Nanomedicine research. The EuroNanoMed partners hope to get the support of the European Commission to be able to continue the successful work in the next years."

Following the first two successful Calls in 2009 and 2010, EuroNanoMed will launch a 3rd Joint Transnational Call for innovative research projects in Nanomedicine in January 2011.

####

About EuroNanoMed
EuroNanoMed aims at leveraging European Nanomedicine through the support of transnational collaborative and multidisciplinary research and technology development projects with participants from academia, clinical/public health communities, and industry. The ERA-Net EuroNanoMed was created to bridge the gap between academic research and industrial and clinical applications, encouraging the participation of small and medium enterprises. The ERA-Net EuroNanoMed initiative comprises 24 partners from 18 European Member- and associated states/regions.

Additional information is available at www.euronanomed.net

About Nanomedicine
Nanomedicine is the application of nanotechnology to medicine and healthcare. The field takes advantage of the physical, chemical and biological properties of materials at the nanometer scale to be used for diagnosis, treatment and follow-up of diseases. Given the immense potential impact of Nanomedicine on public wellbeing and on economic growth, the field is of considerable strategic importance for Europe.

For more information, please click here

Contacts:
EuroNanoMed Contact:
Dr. Virginie Sivan
Coordinator ERA-Net EuroNanoMed
Tel: +33 169-08-87-99


Dr. Olaf Rotthaus
Chair of EuroNanoMed Network Steering Committee
Tel: +49 211-6214-233


Media contact:
Tsipi Haitovsky
Tel: +972-52-598-9892

Copyright © EuroNanoMed

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Keeping electric car design on the right road: A closer look at the life-cycle impacts of lithium-ion batteries and proton exchange membrane fuel cells December 9th, 2016

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Chemical trickery corrals 'hyperactive' metal-oxide cluster December 8th, 2016

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016

Govt.-Legislation/Regulation/Funding/Policy

Chemical trickery corrals 'hyperactive' metal-oxide cluster December 8th, 2016

Researchers peer into atom-sized tunnels in hunt for better battery: May improve lithium ion for larger devices, like cars December 8th, 2016

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016

Exotic insulator may hold clue to key mystery of modern physics: Johns Hopkins-led research shows material living between classical and quantum worlds December 8th, 2016

Nanomedicine

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Journal Nanotechnology Progress International (JONPI) Volume 6, issue 2 coming out soon! December 5th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Announcements

Keeping electric car design on the right road: A closer look at the life-cycle impacts of lithium-ion batteries and proton exchange membrane fuel cells December 9th, 2016

Further improvement of qubit lifetime for quantum computers: New technique removes quasiparticles from superconducting quantum circuits December 9th, 2016

Researchers peer into atom-sized tunnels in hunt for better battery: May improve lithium ion for larger devices, like cars December 8th, 2016

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D: Up-close, real-time, chemical-sensitive 3-D imaging offers clues for reducing cost/improving performance of catalysts for fuel-cell-powered vehicles and other applications December 8th, 2016

Events/Classes

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

In IEDM 2016 Keynote, Leti CEO Says ‘Hyperconnectivity’, Human-focused Research and the IOT Promise Profound, Positive Changes December 7th, 2016

IEDM: Leti CEO Marie Semeria to Give Opening-day Keynote on Impact of ‘Hyperconnectivity’ and IoT: Speech to Portray Key Role Nonprofit Research and Technology Organizations Play in Making Technology More Efficient and Ensuring Safety and Security November 29th, 2016

Leti and Grenoble Partners Demonstrate World’s 1st Qubit Device Fabricated in CMOS Process: Paper by Leti, Inac and University of Grenoble Alpes Published in Nature Communications November 28th, 2016

Nanobiotechnology

Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Year End Results December 7th, 2016

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project